PLASMA INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PREECLAMPSIA

Citation
Y. Kimya et al., PLASMA INTERLEUKIN-1-ALPHA, INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PREECLAMPSIA, European journal of obstetrics, gynecology, and reproductive biology, 73(1), 1997, pp. 17-21
Citations number
20
Categorie Soggetti
Reproductive Biology","Obsetric & Gynecology
ISSN journal
03012115
Volume
73
Issue
1
Year of publication
1997
Pages
17 - 21
Database
ISI
SICI code
0301-2115(1997)73:1<17:PIIAIR>2.0.ZU;2-X
Abstract
The values of plasma interleukin-1 alpha (IL-1 alpha), interleukin-1 b eta (IL-1 beta) and interleukin-l receptor antagonist (IL-1ra) levels were evaluated as the markers of pre-eclampsia in 35 serial plasma sam ples from ten pregnant women who subsequently developed pre-eclampsia and in 74 plasma samples from 20 uncomplicated pregnancies, retrospect ively. No correlation was found between plasma IL-1 alpha, IL-1 beta a nd IL-1ra levels, liver and renal function tests, thrombocyte and whit e blood cell counts, proteinuria, measured in all systolic and diastol ic blood pressures and gestational weeks. Almost equal levels of IL-1 alpha and IL-1 beta were corresponding groups, but these were too few in number to statistically analyze. IL-1ra values were higher in the p re-eclampsia group than in the uncomplicated pregnancy group, at 20-25 and 31-35 gestational weeks significantly and 26-30 gestational weeks insignificantly and showed an increase during labor in both groups. I t was found to have 58% positive predictivity, 100% negative predictiv ity, 50% specificity and 100% sensitivity at gestational weeks 20-25. According to these results, IL-1ra seems to be considered for its high negative predictivity in the exclusion of the probability of pre-ecla mpsia development during antenatal visits, but its plasma level is not correlated with the severity of the disease. (C) 1997 Elsevier Scienc e Ireland Ltd.